Nano-Cap CytomX Therapeutics Stock Surges On Heels Of Cancer Data Report

benzinga.com/general/biotech/25/05/45352601/nano-cap-cytomx-therapeutics-stock-surges-on-heels-of-cancer-data-report

CytomX Therapeutics, Inc.‘s (NASDAQ:CTMX) share price was up 94.46% at last check on Monday.
The stock surged after the company reported interim Phase 1 data for its EpCAM PROBODY ADC candidate, CX-2051, in advanced, late-line colorectal cancer (CRC).
As of April 7, 25 advanced…

This story appeared on benzinga.com, 2025-05-12 15:11:40.
The Entire Business World on a Single Page. Free to Use →